Trial intelligence / Profile preview

INS316 for Sputum Cytology in Lung Cancer Diagnosis

NCT00033527Phase 3Unknown

Sponsor
UCLA Jonsson Comprehensive Cancer Center
Modality
Small Molecules
01

Overview

A Phase 3 trial of uridine triphosphate in lung cancer, sponsored by UCLA Jonsson Comprehensive Cancer Center. Status: unknown.

02

Drugs

uridine triphosphate
03

Conditions

lung cancer

Beyond the preview

Go deeper on NCT00033527.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00033527.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call